The FDA approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations.
News & Blog
GET TO KNOW US!
AllAllergyAsthmaBest PracticesCase StudiesClinical ResearchCNS/NeurologyConsortiaCriterium NewsData ManagementDermatologyEDCFDAGastroenterologyGlobal Clinical ResearchHematologyIndustry NewsInfectious DiseaseIVR-IWR IxRSMedical DevicesMen's HealthMetabolic SyndromeOncologyOphthalmologyOrphan DiseasesOutsourcingPain ManagementPharmaceutical DevelopmentPress ReleasesPublic InterestTranslational ResearchTrial TechnologyUrologyWomen's Health
Over the last two decades, biomedical researchers have begun to unravel cancer’s immense complexity, drilling down to the molecular level to better understand the genetic and biological changes that drive how cancers develop, grow, and spread.
ATOMIC Director Ross Camidge MD, PhD, draws out novel opinions across the field of thoracic oncology from a panel of international experts discussing their favorite ESMO abstracts from 2022.
Industry News: Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma
Eating a Mediterranean diet, rich in fiber, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients.
The FDA approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease.
Industry News: Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct to Anesthesia For Surgical Procedures
The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth's immersive virtual reality software.
- Industry News: FDA Approves New HIV Drug for Adults with Limited Treatment Options
- Industry News: How New Knowledge about Cancer Is Changing Clinical Trials
- Management of toxicities with novel systemic therapies in UC
- International Thoracic Oncology Experts – ESMO Panel Discussion
- Industry News: Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma